IncFact
Company Profiles: Revenue, Growth, Competition

Volastra Therapeutics Revenue, Growth & Competitor Profile

Last updated:

Company Awards

VC / Private Equity
Venture Capital / Private Equity
Fast Growing
Fastest Growing
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Volastra Therapeutics

Access the complete profile.

Volastra Therapeutics Fast Facts

Revenue$10 - $100 million    See Exact Annual Revenue
Employees10 - 100Exact Company Size
Primary Industry5417 Scientific Research & Development Services
Address1361 Amsterdam Avenue Suite 520
New York, NY 10027

Note: Revenues for privately held companies are statistical evaluations.


Volastra Therapeutics's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?
    • Volastra Therapeutics is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Volastra Therapeutics Annual Revenue and Growth Rate

Volastra Therapeutics Revenue Est.
($ Million)
Growth Rate (%)# Employees
2023 $10 - $100 million

Details in Premium Report
2022
2021
2020
2019


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Volastra Therapeutics's revenues are gauged from an analysis of company filings.



Investor Activity

Volastra Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date Investors Percent Raised Target Size
May 30, 2024 2 100%$15 MM
Complete list of funding rounds and total amounts in the Company Report




Volastra Therapeutics's Income Statement (based on Industry Averages)

$ Millions
(Industry Average)
Volastra Therapeutics Revenue (Sales) Volastra Therapeutics Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Trademark Applications

Trademark applications show the products and services that Volastra Therapeutics is developing and marketing. Volastra Therapeutics doesn't have any recent trademark applications, indicating Volastra Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
CIN-AI
Research and development in the pharmaceutical and biotechnology fields; Providing on-line non-downloadable software for image and data analysis in the fields of genomics and chromosomal instability; Providing on-line non-downloadable software for measurement of chromosomal instability; Providing on-line non-downloadable software for measurement and analysis of cancer growth and metastasis
03/25/2021

See all trademarks and details in the Full Report.


Market Share of Volastra Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Volastra Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
LEIDOSDenver, CO100 
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIAAlbuquerque, NM30 
INC RESEARCHRaleigh, NC27 
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORKAlbany, NY17 
FLUOR MARINE PROPULSIONWest Mifflin, PA15 
SYNEOS HEALTHRaleigh, NC13 
ILLUMINASan Diego, CA12 
UT-BATTELLEOak Ridge, TN11 
PRA HOLDINGSRaleigh, NC11 




Nearby Competitors

These companies are similar in business line and location to Volastra Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
ITINew York, NY100 
STEMLINE THERAPEUTICSNew York, NY67 
TG THERAPEUTICSNew York, NY58 
POPULATION COUNCILNew York, NY53 
NEW YORK GENOME CENTERNew York, NY33 
OXFORD NANOPORE TECHNOLOGIESNew York, NY23 




Future Competition: Volastra Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Volastra Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Volastra Therapeutics Competitors